SLC7A11 and glioma: Based on the data described herein, we hypothesize that the samples characterized by elevated xCT expression (WT-12, IDH-2, IDH-3, and DA-1) may be resistant to ferroptosis-inducing therapies and be characterized by elevated glioma uptake of [18F]hGTS13.